Indications |
Oral Depression Adult: As hydrochloride: Initially, 75 mg daily adjusted according to response; up to 300 mg daily in severely depressed patients; 25-50 mg daily in mildly affected patients. Total daily dose >100 mg should be given in divided doses. Child: |
Contraindications |
Hypersensitivity; mania, glaucoma, neonates (topical); lactation. |
Warnings / Precautions |
Epilepsy, CV disease, pregnancy, history of urinary retention, glaucoma; gradual withdrawal. May impair ability to drive or operate machinery. |
Adverse Reactions |
Drowsiness, dizziness, confusion, headache, dry mouth, constipation, blurring of vision, hypotension, tachycardia, rashes. Topical: Burning, stinging, scaling, oedema and dryness. |
Drug Interactions |
Methylphenidate may increase plasma doxepin levels. Potentially Fatal: Potentiates hypertensive action of sympathomimetics. Increased anticholinergic effects with MAOIs. Additive CNS effects with anticholinergics, CNS depressants and alcohol. See Below for More doxepin Drug Interactions |
Mechanism of Actions |
Doxepin inhibits serotonin and norepinephrine re-uptake by the presynaptic neuronal membrane increasing its synaptic conc in the CNS. Absorption: Readily absorbed from the GIT (oral). Distribution: Widely distributed; crosses the blood-brain barrier; enters breast milk. Protein-binding: Extensive. Metabolism: Extensively hepatic via demethylation to desmethyldoxepin, hydroxylation, N-oxidation. Excretion: Urine (as metabolites); 8-24 hrs (elimination half-life). |
Administration |
May be taken with or without food. |
Storage Conditions |
Oral: Store at 15-30°C. |
ATC Classification |
N06AA12 - doxepin ; Belongs to the class of non-selective monoamine reuptake inhibitors. Used in the management of depression. |
Storage |
Oral: Store at 15-30°C. |
Available As |
|
Doxepin
Post Review about Doxepin Click here to cancel reply.
Doxepin Containing Brands
Doxepin is used in following diseases
Drug - Drug Interactions of Doxepin
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.